You just read:

Dragonfly Therapeutics Announces Strategic Collaboration with Celgene to Discover and Develop Novel Natural Killer (NK) Cell-Based Immunotherapies using Dragonfly's TriNKET™ technology platform

News provided by

Dragonfly Therapeutics, Inc.

12 Jun, 2017, 14:02 BST